UnitedHealth Group’s $3.3 billion acquisition of Amedisys faces a new hurdle as the U.S. Department of Justice sued to block the merger, citing concerns over reduced competition in the home health services market. The DOJ argues that merging UnitedHealth and Amedisys would negatively impact patients, insurers, and home health providers. Optum, UnitedHealth’s health services unit, claims the acquisition would drive innovation, calling the DOJ's stance an overreaching interpretation of antitrust laws. Shares of UnitedHealth dropped more than 1%, while Amedisys shares fell over 2%
Category
🗞
NewsTranscript
00:00It's Benzinga bringing Wall Street to Main Street.
00:02UnitedHealth Group's $3.3 billion acquisition of Emeticis faces a new hurdle as the U.S.
00:07Department of Justice filed a lawsuit to block the merger, citing concerns over reduced competition
00:13in the home health services market. The DOJ argues that merging UnitedHealth and Emeticis
00:19would negatively impact patients, insurers, and home health providers. Optum, UnitedHealth's
00:24health services unit, claims the acquisition would drive innovation, calling the DOJ's
00:29stance an overreaching interpretation of antitrust laws. Shares of UnitedHealth
00:34dropped more than 1%, while Emeticis' shares fell over 2%.